| 生物活性 |
Cibotercept (KER-012) is a novel, modified, investigational activin receptor type IIB (ActRIIB) ligand trap designed to target select TGF-β ligands, including activins A and B, GDFs 8 and 11, to rebalance the defective activin receptor type II signaling observed in PAH.
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAS号 |
2769700-97-0
|
||||||||||||
| 运输条件 |
Shipping with dry ice.
|
||||||||||||
| 储存方式 |
|
纯度： 99%
关注我们
获得KKL MED 最新资讯
咨询热线：
400-881-9290
Data Sheet